NS
SOPH icon

NBC Securities’s SOPHiA GENETICS SOPH Stock Holding History

NBC Securities’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.69K Hold
987
– – ﹤0.01% 2045
2026
Q1 		$4.88K Buy
+987
New +$4.8K ﹤0.01% 2124

Other funds holding SOPH

BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

NBC Securities's SOPH Position: Q2 2026 in Review

NBC Securities held its SOPHiA GENETICS (SOPH) position steady in Q2 2026 at 987 shares worth $5.69K. The position accounts for ﹤0.01% of the portfolio, ranked #2045.

NBC Securities first reported a position in SOPH in Q1 2026 and has held it in 2 quarters since. 9 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • NBC Securities held 987 shares of SOPHiA GENETICS worth $5.69K as of Q2 2026.
  • NBC Securities left its SOPHiA GENETICS share count unchanged in Q2 2026.
  • SOPHiA GENETICS made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #2045 holding.
  • NBC Securities first reported a position in SOPHiA GENETICS in Q1 2026 and has held it in 2 quarters since.
  • 9 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.